Beximco Pharmaceuticals (BXP) Competitors GBX 35 0.00 (0.00%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BXP vs. LSE, WPY, AHT, LAND, TW, SAFE, SIR, CLIN, EVR, and BGSCShould you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include London Stock Exchange Group plc (LSE.L) (LSE), Worldpay (WPY), Ashtead Group (AHT), Land Securities Group (LAND), Taylor Wimpey (TW), Safestore (SAFE), Secure Income REIT (SIR), Clinigen Group (CLIN), EVRAZ (EVR), and BMO Global Smaller Companies (BGSC). These companies are all part of the "trading" industry. Beximco Pharmaceuticals vs. Its Competitors London Stock Exchange Group plc (LSE.L) Worldpay Ashtead Group Land Securities Group Taylor Wimpey Safestore Secure Income REIT Clinigen Group EVRAZ BMO Global Smaller Companies London Stock Exchange Group plc (LSE.L) (LON:LSE) and Beximco Pharmaceuticals (LON:BXP) are both large-cap trading companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings. Is LSE or BXP a better dividend stock? London Stock Exchange Group plc (LSE.L) pays an annual dividend of GBX 73 per share. Beximco Pharmaceuticals pays an annual dividend of GBX 3 per share and has a dividend yield of 8.6%. London Stock Exchange Group plc (LSE.L) pays out 64.9% of its earnings in the form of a dividend. Beximco Pharmaceuticals pays out 32.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio. Is LSE or BXP more profitable? Beximco Pharmaceuticals has a net margin of 13.71% compared to London Stock Exchange Group plc (LSE.L)'s net margin of 0.00%. Beximco Pharmaceuticals' return on equity of 13.12% beat London Stock Exchange Group plc (LSE.L)'s return on equity.Company Net Margins Return on Equity Return on Assets London Stock Exchange Group plc (LSE.L)N/A N/A N/A Beximco Pharmaceuticals 13.71%13.12%6.97% Does the media prefer LSE or BXP? In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than London Stock Exchange Group plc (LSE.L). MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for London Stock Exchange Group plc (LSE.L). Beximco Pharmaceuticals' average media sentiment score of 1.16 beat London Stock Exchange Group plc (LSE.L)'s score of 0.00 indicating that Beximco Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment London Stock Exchange Group plc (LSE.L) Neutral Beximco Pharmaceuticals Positive Which has preferable valuation & earnings, LSE or BXP? Beximco Pharmaceuticals has higher revenue and earnings than London Stock Exchange Group plc (LSE.L). London Stock Exchange Group plc (LSE.L) is trading at a lower price-to-earnings ratio than Beximco Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLondon Stock Exchange Group plc (LSE.L)£2.41B0.00N/A£112.40N/ABeximco Pharmaceuticals£7.08T0.00£970.84B£9.323.76 Do institutionals and insiders believe in LSE or BXP? 1.7% of Beximco Pharmaceuticals shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryBeximco Pharmaceuticals beats London Stock Exchange Group plc (LSE.L) on 9 of the 11 factors compared between the two stocks. Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BXP vs. The Competition Export to ExcelMetricBeximco PharmaceuticalsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£23.86B£2.13B£5.56B£2.96BDividend Yield8.67%2.92%5.22%5.02%P/E Ratio3.764.1827.69147.88Price / Sales0.00566.59389.63258,917.23Price / CashN/A10.3536.8927.97Price / Book0.0011.628.034.61Net Income£970.84B£21.15B£3.18B£5.90B7 Day Performance-0.34%1.82%2.93%1.04%1 Month Performance-6.24%6.41%1.72%4.36%1 Year Performance-9.09%2.54%34.39%82.36% Beximco Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BXPBeximco PharmaceuticalsN/AGBX 35flatN/A-9.1%£23.86B£7.08T3.765,500Positive NewsLSELondon Stock Exchange Group plc (LSE.L)N/AN/AN/AN/A£30.31B£2.41B76.694,965WPYWorldpayN/AN/AN/AN/A£29.39B£4.04B194.44190AHTAshtead Group3.8085 of 5 starsGBX 4,710+1.4%GBX 6,345+34.7%-7.2%£25.72B£13.67B16.76120News CoverageDividend CutLANDLand Securities Group1.3414 of 5 starsGBX 619-2.3%GBX 651.50+5.3%-6.2%£4.58B£823.49M-14.35598TWTaylor Wimpey4.0058 of 5 starsGBX 118.45-0.3%GBX 158.33+33.7%-24.0%£4.26B£3.45B17.281,090News CoverageHigh Trading VolumeSAFESafestoreN/AGBX 705.50-0.7%N/A-13.1%£1.54B£222.85M5.81120News CoverageInsider TradeGap DownSIRSecure Income REITN/AN/AN/AN/A£1.49B£122.40M743.55N/ACLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000News CoverageEVREVRAZ0.7938 of 5 starsGBX 81flatN/AN/A£1.18B£15.40B42.1971,591BGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/A Related Companies and Tools Related Companies London Stock Exchange Group plc (LSE.L) Competitors Worldpay Competitors Ashtead Group Competitors Land Securities Group Competitors Taylor Wimpey Competitors Safestore Competitors Secure Income REIT Competitors Clinigen Group Competitors EVRAZ Competitors BMO Global Smaller Companies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BXP) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BXP Stock Alerts